The expression and clinical significance of HERC4 in breast cancer.
BACKGROUND
Increasing evidence suggest that ubiquitin-proteasome system (UPS) plays a key role in tumorigenesis. HERC4 is a recently identified ubiqutin ligase. However, the expression status and biological functions of HERC4 in cancers are not clearly.


METHODS
We evaluated the HERC4 expression in breast cancer cell lines and breast tumor tissues by quantitative real-time PCR and western blot analysis. To investigate the clinicopathological significance of HERC4, immunohistochemistry analysis for HERC4 was performed on a tissue microarray including 13 benign fibroadenoma, 15 intraductal carcinoma, 120 histologically confirmed invasive ductal carcinoma. Receiver operating characteristic (ROC) analysis was applied to determine the optimal cut-off score for positive expression of HERC4, when HERC4 positive expression percentage was above 60%, tumor was defined as "positive".


RESULTS
HERC4 was up-regulated in breast cancer cell lines and breast tumor tissues compared to non-tumorigenic cell line and adjacent normal breast tissues. According to ROC analysis, HERC4 positive expression was detected in 1/16 (6.3%) of normal breast tissue, in 3/13 (23.1%) of fibroadenoma, in 6/15 (40%) of intraductal carcinoma and 66/120 (55%) of invasive ductal carcinoma. Positive expression of HERC4 was positively correlated with pT status, pN status, clinical stage and histological grade of patients with invasive ductal carcinoma (p < 0.05).


CONCLUSIONS
Our findings suggest that HERC4 was a significant diagnostic marker for invasive ductal carcinoma of the breast.
Institute of Genetic Engineering, Southern Medical University, Guangzhou 510515, China.
Hui
H
Zhou
Institute of Genetic Engineering, Southern Medical University, Guangzhou 510515, China.
Rong
R
Shi
Institute of Genetic Engineering, Southern Medical University, Guangzhou 510515, China.
Min
M
Wei
Institute of Genetic Engineering, Southern Medical University, Guangzhou 510515, China.
Wen-Ling
WL
Zheng
Institute of Genetic Engineering, Southern Medical University, Guangzhou 510515, China.
Jue-Yu
JY
Zhou
Institute of Genetic Engineering, Southern Medical University, Guangzhou 510515, China.
Wen-Li
WL
Ma